Pliant Therapeutics Shares Rise After Board Recommendations for Bexotegrast
Pliant Therapeutics shares were up 23% to $3.34 after the company said an independent Data Safety Monitoring Board is allowing it to begin the assembly of an outside expert panel to review unblinded ...
Pliant stock jumps 28% on bexotegrast study update
Pliant Therapeutics (PLRX) stock jumped 21% Thursday after the company issued an update for a Phase 2b clinical study of ...